Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) FCF Margin: 2019-2023

Historic FCF Margin for ADC Therapeutics (ADCT) over the last 3 years, with Sep 2023 value amounting to -257.60%.

  • ADC Therapeutics' FCF Margin fell 25760.00% to -257.60% in Q3 2023 from the same period last year, while for Sep 2023 it was -431.83%, marking a year-over-year decrease of 26534.00%. This contributed to the annual value of -66,218.53% for FY2022, which is 63198001.00% up from last year.
  • Latest data reveals that ADC Therapeutics reported FCF Margin of -257.60% as of Q3 2023, which was down 37.22% from -187.73% recorded in Q2 2023.
  • ADC Therapeutics' FCF Margin's 5-year high stood at 1.06% during Q1 2021, with a 5-year trough of -1,370,995.02% in Q4 2021.
  • In the last 3 years, ADC Therapeutics' FCF Margin had a median value of -1.54% in 2021 and averaged -142,687.79%.
  • Per our database at Business Quant, ADC Therapeutics' FCF Margin soared by 117,295,739bps in 2022 and then crashed by 25,760bps in 2023.
  • ADC Therapeutics' FCF Margin (Quarterly) stood at 0.16% in 2019, then reached -48,914.50% in 2020, then skyrocketed by 4,891,556bps to -1,370,995.02% in 2021, then surged by 117,295,739bps to -198,037.63% in 2022, then plummeted by 25,760bps to -257.60% in 2023.
  • Its FCF Margin was -257.60% in Q3 2023, compared to -187.73% in Q2 2023 and -86.39% in Q1 2023.